Valentina Lacmanovic Loncar

Dr. Valentina Lacmanovic Loncar

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2008 in British Journal of Ophthalmology
Verified
Journal Article
Closed access
PDF file
GBG Bencic
G Bencic
ZVZoran Vatavuk
Zoran Vatavuk
MMM Marotti
M Marotti
VLValentina Lacmanovic Loncar
Valentina Lacmanovic Loncar
IPI Petric
I Petric
ZMZ Mandic
Z Mandic
Aims: The aim of the study was to compare the accuracy of A-scan biometry and MRI for the measurement of axial length in silicone oil-filled eyes. Methods: This was a prospective randomised study of 70 patients. Biometry was performed using MRI in 33 patients (MRI group) and A-scan echography in 37 patients (A-scan group). The difference between predicted and final refraction was measured and evaluated statistically. Results: In patients with axial length ⩾26 mm, the mean deviation of the final from predicted refraction was −1.23 (SD 0.67) D in the MRI group and −2.3 (SD 2.02) D in the A-scan group. The difference between these two groups was statistically significant (p = 0.02). In patients with axial length <26 mm, the mean deviation of the final from predicted refraction was −0.12 (SD 1.29) D in the MRI group and −0.33 (SD 1.39) D in the A-scan group. There was no statistical significance between the two groups (p = 0.629). Conclusion: For highly myopic patients MRI biometry was a more accurate measurement of axial length in silicone oil-filled eyes. A-scan and MRI biometry were comparably accurate in measuring axial length in patients with axial length <26 mm.



11 October 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
FBFreja Bagatin
Freja Bagatin
IRIvana Radman
Ivana Radman
KRKarla Randelovic
Karla Randelovic
IVIvanka Petric Vicković
Ivanka Petric Vicković
VLValentina Lacmanovic Loncar
Valentina Lacmanovic Loncar
ZVZoran Vatavuk
Zoran Vatavuk
Corneal crosslinking (CXL) is a medical procedure used to treat keratoconus. CXL works by strengthening the collagen fibers of the cornea through the application of riboflavin (vitamin B2) and ultraviolet (UV) light, which helps to stabilize the cornea and prevent further deterioration. There is a recognized risk that CXL can trigger the reactivation of dormant herpes simplex virus (HSV), leading to herpetic keratitis even in patients with no history of herpetic disease. We examined the medical history of 52 patients who underwent CXL procedures due to previously diagnosed keratoconus. We reviewed the patient’s medical histories to assess whether there was a herpes labialis infection and/or herpetic keratitis. Altogether, 52 eyes (from 52 patients) were analyzed. Of those, four (7.69%) patients were diagnosed with epithelial herpetic keratitis on the 5–8th day after surgery. All four patients had a history of herpes labialis and no prior HSV keratitis infection. Two patients developed herpetic keratitis despite prophylactic therapy with acyclovir 5 days before surgery. A positive history of HSV lip infection before CXL was present in 18/52 (34.62%). During a one-year follow-up period, no patient experienced a recurrence. Close follow-up is crucial for diagnosing herpetic keratitis after corneal crosslinking. The use of prophylactic antiviral therapy in patients who are asymptomatic and have a history of recurrent herpes labialis does not guarantee the prevention of infection.

1 June 2012
Verified
Journal Article
Closed access
VLValentina Lacmanovic Loncar
Valentina Lacmanovic Loncar
IVIvanka Petric Vicković
Ivanka Petric Vicković
RIRenata Iveković
Renata Iveković
ZMZdravko Mandić
Zdravko Mandić

1 January 2006
Verified
Journal Article
Closed access
VLValentina Lacmanovic Loncar
Valentina Lacmanovic Loncar
IPIvanka Petric
Ivanka Petric
ZVZoran Vatavuk
Zoran Vatavuk
TMTea Musulin
Tea Musulin
KNKatia Novak-Laus
Katia Novak-Laus
ZMZdravko Mandić
Zdravko Mandić